Related Topics News -

     
 Title only   |   Print 
     
亞盛醫藥六項研究入選美國臨床腫瘤學會年會摘要

2026-05-22T  
亞盛醫藥多項研究入選2026 ASCO

2026-04-22T  
《大行》摩通降亞盛醫藥目標價至89元 續予「增持」評級

2026-04-21T  
亞盛醫藥四項臨床前進展將於今年美國癌症研究協會以壁報形式公布

2026-04-20T  
《業績》亞盛醫藥去年虧損擴大至12.43億人民幣

2026-03-26T  
亞盛醫藥將於美國癌症研究協會年會公布四項最新臨床前研究進展

2026-03-18T  
亞盛醫藥新藥「奧雷巴替尼」全球註冊三期臨床研究獲批

2025-12-05T  
亞盛醫藥發布耐立克等多項產品臨床進展

2025-11-04T  
內地首七月有50款創新藥獲批上市 超去年全年

2025-09-17T  
《大行》花旗大幅升亞盛醫藥目標價至114元 評級「買入」

2025-08-22T  

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.